Anti-tumor cell antigen antibody therapeutics

Details for Australian Patent Application No. 2007227224 (hide)

Owner Novartis AG

Inventors Janatpour, Mary J.; Yu, Guoying K.

Agent FB Rice

Pub. Number AU-A-2007227224

PCT Pub. Number WO2007/109376

Priority 60/785,704 23.03.06 US

Filing date 22 March 2007

Wipo publication date 27 September 2007

International Classifications

A61K 39/00 (2006.01) Medicinal preparations containing antigens or antibodies

A61K 47/48 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

C07K 16/30 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Event Publications

9 October 2008 PCT application entered the National Phase

  PCT publication WO2007/109376 Priority application(s): WO2007/109376

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007227227-Method and system of coordinating an intensifier and sieve beds

2007227218-Methods for identifying polypeptide targets and uses thereof for treating immunological diseases